SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

BATISTA-DUHARTE, Alexander. Vacunas y autoinmunidad: una rara asociación bajo debate. Rev Peru Med Exp Salud Publica [online]. 2012, vol.29, n.2, pp. 265-271. ISSN 1726-4634.  http://dx.doi.org/10.1590/S1726-46342012000200017.

    1. Rose NR. Autoimmunity, infections and adjuvants. Lupus. 2010;19(4):354-8. [ Links ]

    2. Orbach H, Shoenfeld Y. Vaccination, infection and autoimmunity: myth and reality VIAMR 2005-10-26- 28, Beau-Rivage Palace Hotel, Lausanne, Switzerland. Autoimmunity Rev. 2007(6):261-6. [ Links ]

    3. Chen RT, Pless R, DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 2001;16(3):309-18. [ Links ]

    4. Alvord EC, Kies MW, Suckling AJ. Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. In : Alvord EC, Kies MW, Suckling AJ (Eds). Progress in Clinical and Biological Research. New York; Alan R Liss Inc; 1984. p. 523-37. [ Links ]

    5. Burkhardt H, Kalden JR. Animal models of autoimmune diseases. Rheumatol Int. 1997;17(3):91-9. [ Links ]

    6. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 1998;12(13):1255-65. [ Links ]

    7. Geier DA, Geier MR. Hepatitis B vaccination and arthritic adverse reactions: a follow-up analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol. 2002;20(1):119. [ Links ]

    8. Herroelen L, de Keyser J, Ebinger G. Central-nervoussystem demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991;338(8776):1174-5. [ Links ]

    9. Gout O, Lyon-Caen O. Sclerotic plaques and vaccination against hepatitis B. Rev Neurol (Paris). 1998;154(3):205-7. [ Links ]

    10. Vial T, Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol. 2004;14(2):86-90. [ Links ]

    11. Duclos P. Safety of immunization and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf. 2003;2(3):225-31. [ Links ]

    12. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine. 2005;23(30):3876-86. [ Links ]

    13. Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev. 2005;4(2):96-100. [ Links ]

    14. Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol. 2005;12(3):217-24. [ Links ]

    15. Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet. 1991;337(8751):1183-7. [ Links ]

    16. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain–Barré syndrome following influenza vaccination. JAMA. 2004;292(20):2478-81. [ Links ]

    17. Schoenberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, et al. Guillain– Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-- 1977. Am J Epidemiol. 1979;110(2):105-23. [ Links ]

    18. Lasky T, Terracciano Gj, Madger L, Koski CL, Ballesteros M, Nash D, et al. The Guillain–Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med. 1998;339(25):1797-802. [ Links ]

    19. Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome small star, filled. Clin Immunol. 2003;107(2):116-21. [ Links ]

    20. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel. Pediatr Infect Dis J. 1999;18(3):217-22. [ Links ]

    21. Karvonen M, Cepaitis Z, Tuomilehto J. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ. 1999;318(7192):1169- 72. [ Links ]

    22. Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review. Vaccine. 2011;29(28):4544-55. [ Links ]

    23. Barrett AD, Teuwen DE. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol. 2009;21(3):308-13. [ Links ]

    24. Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine. 2005;23(25):3256-63. [ Links ]

    25. Shoenfeld Y, Agmon-Levin N. ‘ASIA’ - autoimmune/ inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4-8. [ Links ]

    26. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998; 41(1):58-67. [ Links ]

    27. Pitkanen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 2003;4(1):12- 21. [ Links ]

    28. Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol. 2006;18(6):665-9. [ Links ]

    29. Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett. 2011;203(2):97-105. [ Links ]

    30. Waisbren BA Sr. Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns. Med Hypotheses. 2008;70(2):346-8. [ Links ]